Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems
Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems
批准号:
9356494
负责人:
BRUCE L. LAMBERT
金额:
$39.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2021-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Wrong-drug and wrong-patient errors occur at a rate of roughly one per thousand orders in inpatient and
outpatient settings, resulting in millions of potentially harmful errors annually in the US. Accurate problem lists
help prevent wrong-drug and wrong-patient errors by allowing the electronic medical record (EMR) to remind
prescribers when orders do not match the problem list. Unfortunately, problem lists are often inaccurate.
Indication alerts prompt prescribers to add new problems to the problem list when a drug order does not match
the problem list. Indication alerts also promote self-interception of wrong-drug and wrong-patient errors by
increasing situation awareness. Two types of self-interception events can be measured in an automated way:
(a) abandon-and-reorder—a prescriber starts then abandons an incorrect order before signing it, and then re-
orders for the correct drug or patient; or (b) retract-and-reorder—a prescriber cancels an incorrect order soon
after signing it, and then re-orders for the correct drug or patient. Previous work used the abandon-and-reorder
and retract-and-reorder methods to measure the effectiveness of several interventions, including indication
alerts, in reducing wrong-drug and wrong-patient errors, but that work was limited. First, only a small number of
drugs were studied. Second, prior studies were done at a single medical center and involved only one
commercial EHR. Third, until 2016, there was no validated, National Quality Forum-endorsed instrument for
estimating the rate of wrong-patient orders. Fourth, the prior studies of indication alerts used posttest only
designs and therefore could not test for an increase in the self-interception rate over baseline. The proposed
project addresses these limitations in the earlier work and fills important gaps in knowledge about how to prevent
wrong-drug and wrong-patient errors and how to improve the completeness of problem lists. The project's
Specific Aims are: 1. At one hospital in Chicago and six in New York City, using two commercial EMR systems,
implement a set of 30-50 indication alerts for medications that are vulnerable to look-alike and sound-alike errors.
2. Using an interrupted time series study design, quantify the effect of indication alerts on (a) the combined rate
of self-intercepted wrong-drug and wrong-patient computerized prescriber order entry (CPOE) errors and (b) on
the rate of each type of error viewed separately. It is predicted that indication alerts will increase the combined
rate of self-intercepted wrong-drug and wrong-patient errors by roughly 25%, from 158 to 196 events per 100,000
orders, and will increase the self-interception rate of each type when viewed separately, as measured by an
increase in the sum of abandon-and-reorder and retract-and-reorder events. 3. Assess the impact of indication
alerts on the probability of adding new diagnoses to the problem list during encounters that include CPOE. It is
predicted that indication alerts will double the likelihood that a problem is placed on the problem list during
encounters that include CPOE, with new problems being placed during 12% of pre-intervention orders and 25%
of post-intervention orders. The intervention should add to knowledge and improve quality and patient safety.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems
-
批准号:10013218
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2016
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Medication Safety (TOP-MEDS)
-
批准号:8739629
-
项目类别:
-
资助金额:$84.08万
-
财政年份:2011
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Medication Safety (TOP-MEDS)
-
批准号:8492029
-
项目类别:
-
资助金额:$95.5万
-
财政年份:2011
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Medication Safety (TOP-MEDS)
-
批准号:8265048
-
项目类别:
-
资助金额:$84.88万
-
财政年份:2011
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Medication Safety (TOP-MEDS)
-
批准号:8335145
-
项目类别:
-
资助金额:$84.29万
-
财政年份:2011
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Medication Safety (TOP-MEDS)
-
批准号:8917143
-
项目类别:
-
资助金额:$83.76万
-
财政年份:2011
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Prescribing, Monitoring and Education
-
批准号:7489964
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2007
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Prescribing, Monitoring and Education
-
批准号:7874547
-
项目类别:
-
资助金额:$97.69万
-
财政年份:2007
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Prescribing, Monitoring and Education
-
批准号:7333917
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2007
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Tools for Optimizing Prescribing, Monitoring and Education
-
批准号:7686747
-
项目类别:
-
资助金额:$99.78万
-
财政年份:2007
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Auditory Perception of Drug Names: Neighborhood Effects
-
批准号:6617155
-
项目类别:
-
资助金额:$48.94万
-
财政年份:2003
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Auditory Perception of Drug Names: Neighborhood Effects
-
批准号:6918743
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2003
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Auditory Perception of Drug Names: Neighborhood Effects
-
批准号:6752873
-
项目类别:
-
资助金额:$38.27万
-
财政年份:2003
-
负责人:BRUCE L. LAMBERT
-
依托单位:
Auditory Perception of Drug Names: Neighborhood Effects
-
批准号:7088864
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2003
-
负责人:BRUCE L. LAMBERT
-
依托单位:
海外基金